“…Concerning the quality of the preclinical studies, three out of the 16 were labeled as H (18.8%) [ 30 , 37 , 38 ], 10 as MH (62.5%) [ 31 , 32 , 33 , 34 , 35 , 36 , 40 , 43 , 44 , 45 ], and the remaining three as ML-quality (18.8%) [ 39 , 41 , 42 ]. In a similar vein, 37 out of 45 human studies were classified as VH (82.2%) [ 46 , 48 , 49 , 50 , 51 , 52 , 53 , 56 , 57 , 58 , 59 , 61 , 63 , 64 , 65 , 66 , 67 , 70 , 71 , 72 , 73 , 74 , 75 , 76 , 77 , 80 , 81 , 82 , 83 , 84 , 85 , 87 , 88 , 89 , 90 , 91 ], 7 as H (15.6%) [ 47 , …”